ThredUp Announces First Quarter 2025 Results
GlobeNewswire· 2025-05-05 20:05
All results reported are for continuing operations, unless otherwise noted. Record quarterly revenue of $71.3 million, representing an increase of 10% year-over-yearQuarterly gross margin of 79.1% and an increase in gross profit of 9% year-over-yearActive Buyers of 1.37 million, representing growth of 6% year-over-year, with new buyer growth of 95% year-over-year, reflecting ThredUp’s best quarter for new buyer acquisition in its historyEnded the quarter with cash, restricted cash, and investments of $55.4 ...
Mission Produce® Appoints Michael Sims to Board of Directors
GlobeNewswire· 2025-05-05 20:05
OXNARD, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today announced the appointment of Michael Bryan Sims to its board of directors, effective May 5, 2025. Sims is appointed as an independent Class I director, serving on the audit committee, with a term expiring at the Company’s 2028 Annual Meeting of Stockholders. In ...
James River Announces Excess and Surplus Lines Leadership Retirement and Succession Plan
GlobeNewswire· 2025-05-05 20:05
Richard Schmitzer to Retire as President and Chief Executive Officer, Excess and Surplus Lines; Todd Sutherland Will Succeed Him as President, Excess and Surplus Lines, Effective May 5, 2025PEMBROKE, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) announced today its plans for Todd Sutherland, current Senior Vice President, Management Liability within the Company’s Excess and Surplus Lines (“E&S”) segment, to succeed Richard Schmitze ...
Context Therapeutics Announces Chief Medical Officer Transition
GlobeNewswire· 2025-05-05 20:05
Board Member Dr. Karen Smith to serve as Interim Chief Medical OfficerPHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, MD, PhD, MBA, LLM as interim Chief Medical Officer (“CMO”). Dr. Smith replaces Dr. Claudio Dansky Ullmann, who will be leaving the Company effective May 10, 2025. Dr. Smith will continue ...
Upwork Reports First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-05 20:03
Achieves record first quarter with revenue of $192.7 million, GAAP net income of $37.7 million and adjusted EBITDA of $56.0 million, resulting in 20% profit margin and 29% adjusted EBITDA marginReiterates FY2025 revenue guidance and raises full-year adjusted EBITDA guidance PALO ALTO, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with independent talent from across the globe, today announced its financial results for the fi ...
Navitas Semiconductor Announces First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-05 20:03
GaN expected production ramp in new mainstream markets in AI data centers, solar micro-inverters and EV over next 12 monthsGaN sets industry benchmark with over 250M shipped and 100ppb field reliabilitySiC sets industry benchmark with reliability exceeding AEC standards and ultra-high voltage 2.3kV to 6.5V, with expansion into commercial EVs TORRANCE, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the only pure-play, next-generation power semiconductor company and industry le ...
CIVI INVESTOR ALERT: Civitas Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead the Civitas Resources Class Action Lawsuit
Prnewswire· 2025-05-05 20:03
SAN DIEGO, May 5, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Civitas Resources, Inc. (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, inclusive (the "Class Period"), have until July 1, 2025 to seek appointment as lead plaintiff of the Civitas Resources class action lawsuit. Captioned Lin v. Civitas Resources, Inc., No. 25-cv-03791 (D.N.J.), the Civitas Resources class action lawsuit charges Civitas Resources and certain of Civitas ...
Gibson Energy Declares Dividend
GlobeNewswire· 2025-05-05 20:02
All financial figures are in Canadian dollars unless otherwise noted CALGARY, Alberta, May 05, 2025 (GLOBE NEWSWIRE) -- Gibson Energy Inc. (TSX:GEI) (“Gibson”, or the “Company”) announced today that its Board of Directors has approved a quarterly dividend of $0.43 per common share, payable on July 17, 2025, to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an eligible dividend for Canadian income tax purposes. For non-resident shareholders, Gibson's dividend ...
ARRAY Technologies Enhances ARRAY STI H250™ Tracker with SmarTrack® Backtracking and Diffuse Capabilities
GlobeNewswire News Room· 2025-05-05 20:02
ALBUQUERQUE, N.M., May 05, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced the expansion of its SmarTrack® software to include backtracking and diffuse optimization capabilities for its ARRAY STI H250™ dual-row tracker. This advancement brings algorithm training and optimization tools, already proven on the DuraTrack® platform, to H250 installations across Europe and ...
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
GlobeNewswire News Room· 2025-05-05 20:02
Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2025. Recent Business Highlights Generated revenue of $201.3 ...